Status: Recruiting
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
This is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, a pair of matching index wounds will be randomly assigned to be treated with a local application of either TCP 25 gel or vehicle gel.
Participants needed: 32
Trial details
Phase: Phase 2Age: 4+Biological sex: AllType: InterventionalSponsor: Xinnate ABUpdated: May 20, 2026Locations: 9
Eligibility criteria
Male or female patients with documented diagnosis of DEB or JEB, confirmed by ge... [+1]
The patient has any subtype of EB other than DEB or JEB. [+1]